Position in NXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,881
+$7,635 QoQ
Shares Held
2,513
+144.0% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 20 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NXL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $3,447,350,274 across 95 Medical Devices names. NXL ranks #88 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
8,597,227 | $780,112,377 | |
| 2 | MDT |
Medtronic plc
|
5,373,877 | $420,398,397 | |
| 3 | EW |
Edwards Lifesciences Corp
|
3,997,925 | $361,652,295 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
3,477,472 | $299,375,563 | |
| 5 | BSX |
Boston Scientific Corp
|
4,987,748 | $212,877,084 | |
| 6 | GKOS |
GLAUKOS Corp
|
1,390,017 | $194,268,775 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
2,367,032 | $151,513,717 | |
| 8 | PEN |
Penumbra Inc
|
448,763 | $141,696,917 |
All Filings in NXL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,881 | 75,398 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $17,246 | 30,907 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $36,841 | 37,289 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $38,925 | 58,185 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $6,621 | 15,048 | Shares | Defined | 2023-11-14 | |
| 2022-09-30 | $16,719 | 15,481 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||